Antitrust Antitrust

Teva goes to EU court over Cephalon antitrust fine

By Lewis Crofts
  • 11 Feb 2021 04:47
  • 11 Feb 2021 05:15
Teva filed an EU court appeal this month to contest a fine of 60.5 million euros ($73 million) imposed on it and Cephalon for delaying the market entry of a cheaper drug to treat sleep disorders.

In November, the European Commission wrapped up a probe into a 2005 agreement between Teva and US peer

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News